Delivery Order SPE2DB20D1047-SPE2DB25FF73B
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Candesartan Cilexetil 16 mg tablets in a quantity of 90 units, with a ceiling value of $13,581.09. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 24,...
- The Defense Logistics Agency awarded a $4,126.96 delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Candesartan Cilexetil 16 mg tablets (90-count bottles). This competitive, non-set-aside contract utilizes firm fixed pricing and carries an ultimate completion date of July 22, 2025. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. Candesartan Cilexetil is an angiotensin II receptor blocker commonly prescribed...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,163.90 to AmerisourceBergen Drug Corp for the supply of Candesartan Cilexetil 16 mg tablets (90-count units). This non-set-aside, competitively awarded contract is structured as a firm fixed price delivery order with a completion date of July 30, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Candesartan cilexetil is an angiotensin receptor blocker used for...
- The Defense Logistics Agency awarded a $40,296.55 delivery order to AmerisourceBergen Drug Corp for 90 tablets of Candesartan Cilexetil 32 mg, with an ultimate completion date of August 5, 2025. This is a firm fixed-price, non-set-aside contract executed under a competitive procurement process. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location in the same city. The delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Candesartan Cilexetil 32 mg tablets (90-count) with a ceiling value of $53,240.96. This firm fixed-price delivery order, with an ultimate completion date of August 4, 2025, represents a non-set-aside competitive award issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The contract will be performed at the vendor's...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Candesartan Cilexetil 4 mg tablets (90-count) with a ceiling value of $1,171.70. This competitive, non-set-aside delivery order represents a firm fixed-price transaction with an ultimate completion date of July 22, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award falls under the...
- The Defense Logistics Agency awarded a $1,506.40 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Candesartan Cilexetil 16 mg tablets (90-count bottles). Awarded on July 22, 2025, with an ultimate completion date of July 23, 2025, this contract represents a competitive award with no set-aside designation. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and serves as...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Candesartan Cilexetil 16 mg tablets (90-count) valued at $7,694.19 under a firm fixed price contract. This non-competitive, non-set-aside delivery order was awarded on July 31, 2025, with an ultimate completion date of August 1, 2025. The pharmaceutical product will be delivered to the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at approximately $62,000 to AmerisourceBergen Drug Corp for the supply of Candesartan Cilexetil 32 mg tablets (90 count). The contract, awarded on August 5, 2025, with an ultimate completion date of August 6, 2025, represents a firm fixed-price transaction with no set-aside designation. The pharmaceutical product will be delivered to the contractor's location in Conshohocken, Pennsylvania. This delivery order is a child contract issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Candesartan Cilexetil 32 mg tablets (90-count units) with a ceiling value of $3,511.93. This firm fixed-price delivery order, with an ultimate completion date of August 6, 2025, represents a competitive award with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains...
- SPE2DB20D1047Indefinite Delivery Contract
- SPE2DB20D1047-SPE2DB25FF73BDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,084.47 to AmerisourceBergen Drug Corp for the supply of Candesartan Cilexetil 4 mg tablets in a quantity of 90-count units. This contract was awarded on July 18, 2025, under a firm fixed-price arrangement with an ultimate completion date of July 21, 2025. The award represents a non-competitive, non-set-aside delivery order and will be performed at the vendor's facility in Conshohocken, Pennsylvania. Candesartan cilexetil is an angiotensin II receptor blocker commonly prescribed for hypertension management, indicating this procurement supports the pharmaceutical supply requirements of the Department of Defense and associated military healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026 that enables the company to supply comprehensive pharmaceutical products and medical commodities globally. As a leading pharmaceutical distributor and healthcare solutions provider headquartered in Pennsylvania, AmerisourceBergen serves as a critical vendor for federal medical procurement, with its contract portfolio encompassing extensive offerings of brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains supporting military and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.1k | 7/18/25 |